NRx Pharmaceuticals: Latest News, Top Stories & Analysis - Page 2 of 2

NRx Pharmaceuticals Makes Significant Stride with New Depression Drug, Aims for Accelerated FDA Approval

May 13, 2024May 12, 2024 - by Timothy Alexander

RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) recently highlighted a compelling advantage in safety for its drug NRX-101, in comparison to the standard treatments offered in its latest clinical trial. …

Regional

NRx Pharmaceuticals Breakthrough Drug Shows Potential to Reduce Suicide Risk in Bipolar Depression Patients

May 6, 2024May 5, 2024 - by Timothy Alexander

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) disclosed encouraging preliminary outcomes from a study on NRX-101, an investigational drug designated as a breakthrough therapy. The drug demonstrated a promising, …